GAMA
ICPT

Graticule Asia Macro Advisors’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Graticule Asia Macro Advisors’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-27,038
Closed -$3.47M – 97
2016
Q1 		$3.47M Buy
+27,038
New +$3.19M 0.27% 61

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Graticule Asia Macro Advisors's ICPT Position: Q2 2016 in Review

Graticule Asia Macro Advisors sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q2 2016, closing a stake of 27,038 shares — an estimated $3.47M sold.

Graticule Asia Macro Advisors first reported a position in ICPT in Q1 2016 and held it in 1 quarter. The position peaked at $3.47M in Q1 2016. 167 funds tracked by Wall St. Rank hold ICPT as of Q2 2016.

  • Graticule Asia Macro Advisors reported no remaining Intercept Pharmaceuticals, Inc. position as of Q2 2016 after selling out during the quarter.
  • Graticule Asia Macro Advisors sold 27,038 Intercept Pharmaceuticals, Inc. shares in Q2 2016, an estimated $3.47M.
  • Graticule Asia Macro Advisors first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2016 and held it in 1 quarter.
  • Graticule Asia Macro Advisors's Intercept Pharmaceuticals, Inc. position peaked at $3.47M in Q1 2016.
  • 167 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q2 2016.

Based on Graticule Asia Macro Advisors's 13F filing for Q2 2016, filed 15 Aug 2016.